Technivie
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Technivie: combination pack of three medications, ombitasvir/paritaprevir/ritonavir. Indicated for the treatment of chronic hepatitis C virus (HCV) genotype 4 infection without cirrhosis with or without the addition of ribavirin.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Technivie: combination pack of three medications, ombitasvir/paritaprevir/ritonavir. Indicated for the treatment of chronic hepatitis C virus (HCV) genotype 4 infection without cirrhosis with or without the addition of ribavirin.
There's more to see -- the rest of this entry is available only to subscribers.